Navigation Links
Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems
Date:4/1/2008

BOTHELL, Wash., April 1, 2008 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it signed a letter of intent to begin establishing Heartcentrix(R) ECG connectivity with the Misys MyWay(TM) electronic medical record (EMR) system from Misys Healthcare.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

Misys Healthcare serves more than 100,000 physicians in 18,000 practice locations. "Misys MyWay integrates EMR, practice management, and claims management to offer a simple, affordable, complete solution for physicians and clinicians," Paul Edge, Vice President, Clinical Solutions for Misys Healthcare said. "With this agreement, thousands of our customers have the potential to access information from new or currently installed Burdick and Quinton electrocardiograph (ECG) devices, stress systems, and Holter devices while using our Misys MyWay EMR systems."

The HeartCentrix solution from Cardiac Science helps bring patient history, clinical charting, e-prescribing, lab orders, results, and patient follow-up information together into a single EMR application. "We designed HeartCentrix to streamline diagnostic cardiology workflow," said Greg Newman, senior marketing manager for Cardiac Science. "Ultimately, the patient benefits. With streamlined integration, physicians have easier access to information, faster results, and fewer chances for operator error, patients receive a higher standard of care."

Tony Titus, Cardiac Science vice president of marketing added, "The agreement with Misys Healthcare is another step in our goal to connect our diagnostic cardiology products seamlessly with all major EMR solution providers. We're very much looking forward to this partnership."

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

About Misys Healthcare Systems, LLC

Misys Healthcare -- part of the global application software and services company, Misys plc (FTSE: MSY.L) -- delivers integrated, comprehensive solutions that improve results for healthcare practitioners. Drawing on our decades of healthcare experience, our relationships with more than 100,000 healthcare professionals, and our commitment to customer success, we deliver innovative software and services that enable physicians, caregivers, and a connected healthcare community. Misys Healthcare: Experience, Solutions, Results. Contact us today; visit http://www.misyshealthcare.com.

Forward Looking Statements

This press release contains forward-looking statements. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Forward looking statements in this press release include those that infer or imply that the revenue and profits of Cardiac Science may increase as a result of the connectivity of its products with those of Misys, as well as other risks that are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2006. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

Company Contact: Investor Contact: Media Contact:

Mike Matysik Jenifer Kirtland Christopher Gale

Cardiac Science Corporation EVC Group, Inc. EVC Group, Inc.

Sr. Vice President and CFO (415) 896-6820 (201) 646-5431

(425) 402-2009 (203) 570-4681

cgale@evcgroup.com CSCX - G


'/>"/>
SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cardiac Science Unveils Major Brand Change; Strategy to Lift Brand Awareness
2. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
3. New research shows that iPods do not interfere with cardiac pacemakers
4. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
5. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
6. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
7. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
8. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
9. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
10. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Thomson Scientific Begins Expansion of Web of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... control cells — optogenetics — is key to exciting advances in the study ... spatially patterned light projected via free-space optics stimulates small, transparent organisms and excites ...
(Date:12/8/2016)... Mass (PRWEB) , ... December 08, 2016 , ... ... genetic data bioInformatics portal. In response to client demand KbioBox developed a sophisticated ... edit biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... 2016   Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
Breaking Biology Technology:
(Date:12/5/2016)... 5, 2016  The Office of Justice Programs, ... CT Scans Enhance or Replace Medico Legal Autopsies?" ... supporting or replacing forensic autopsies with postmortem X-ray ... In response to recommendations made by The ... CT scans as a potential component of medicolegal ...
(Date:11/29/2016)... 2016 BioDirection, a privately held medical device ... objective detection of concussion and other traumatic brain injury ... a meeting with the U.S. Food and Drug Administration ... Package. During the meeting company representatives reviewed plans for ... to commencement of a planned pilot trial. ...
(Date:11/22/2016)... 22, 2016 According to the new market research ... Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and ... the market is expected to grow from USD 10.74 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):